HomePMVP • NASDAQ
add
PMV Pharmaceuticals Inc
Previous close
$1.50
Day range
$1.46 - $1.51
Year range
$0.81 - $1.88
Market cap
78.39M USD
Avg Volume
885.25K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 19.24M | 3.75% |
Net income | -18.04M | 21.58% |
Net profit margin | — | — |
Earnings per share | -0.34 | 24.44% |
EBITDA | -19.21M | -3.79% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 112.94M | -33.35% |
Total assets | 116.56M | -39.06% |
Total liabilities | 11.85M | -22.08% |
Total equity | 104.71M | — |
Shares outstanding | 53.33M | — |
Price to book | 0.77 | — |
Return on assets | -38.42% | — |
Return on capital | -42.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -18.04M | 21.58% |
Cash from operations | -17.19M | -3.17% |
Cash from investing | 18.44M | 138.17% |
Cash from financing | 392.00K | 127.91% |
Net change in cash | 1.65M | 118.80% |
Free cash flow | -10.63M | -31.81% |
About
Founded
2013
Website
Employees
54
